Inspire Medical Systems Downgraded Despite $204.5M Q1 Revenue and $0.10 EPS
INSP•Piper Sandler cut its rating on Inspire Medical Systems from Overweight to Neutral despite the company reporting adjusted EPS of $0.10 and over $204.5 million in Q1 revenue, marking 1.6% year-on-year growth. The quarter also delivered $12.8 million in operating cash flow as management emphasized disciplined cost control and revenue growth.
1. Rating Downgrade Overview
Piper Sandler shifted its rating on Inspire Medical Systems from Overweight to Neutral, signaling expectations for performance in line with market peers rather than outperformance.
2. First-Quarter Financial Results
The company reported adjusted diluted earnings per share of $0.10 and generated revenue exceeding $204.5 million, representing a 1.6% increase year over year and surpassing consensus estimates by nearly 3%.
3. Operating Cash Flow and Strategy
Inspire delivered $12.8 million in operating cash flow for the quarter, with management emphasizing disciplined cost management and targeted revenue-generating initiatives to support sustained growth.
